Johnson & Johnson’s Covid-19 vaccine was supposed to be the uncomplicated one. But even with new data, getting people to trust it again will be tricky.
Despite the hastily called press conference on Tuesday, the late-night meetings, and the growing worry over a potentially fatal side effect, the decision to pause the use of one of the three Covid-19 vaccines available in the United States was a relatively easy one.
Figuring out how to unpause, though—that’s going to be a lot trickier.
The public health community had some hope that the Centers for Disease Control and Prevention might find a fast path through the data fog. But that vanished late Wednesday, when
→ Continue reading at Wired - Science